| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |